Antithrombin Cambridge, 384 Ala to Pro: a new variant identified using the polymerase chain reactionPERRY, D. J; HARPER, P. L; FAIRHAM, S et al.FEBS letters. 1989, Vol 254, Num 1-2, pp 174-176, issn 0014-5793, 3 p.Article

Antithrombin : Early prophecies and present challengesABILDGAARD, Ulrich.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 97-104, issn 0340-6245, 8 p.Article

Antithrombin Affects Hemostatic Response to Recombinant Activated Factor VII in Factor VIII Deficient PlasmaSZLAM, Fania; TAKETOMI, Taro; SHEPPARD, Chelsea A et al.Anesthesia and analgesia. 2008, Vol 106, Num 3, pp 719-724, issn 0003-2999, 6 p.Article

Conformation of the pentasaccharide corresponding to the binding site of heparin to antithrombin-IIIRAGAZZI, M; FERRO, D. R; PERLY, B et al.Carbohydrate research. 1987, Vol 165, Num 1, pp C1-C5, issn 0008-6215Article

Antithrombins : their potential as antithrombotic agentsWEITZ, J. I; HIRSH, J.Annual review of medicine. 1992, Vol 43, pp 9-16, issn 0066-4219Article

The effect of dilution on plasma coagulation kinetics determined by thrombelastography is dependent on antithrombin activity and mode of activationNIELSEN, Vance G; LYERLY, Ralph T; GURLEY, William Q et al.Anesthesia and analgesia. 2004, Vol 99, Num 6, pp 1587-1592, issn 0003-2999, 6 p.Article

Antithrombin III and arterial diseaseCORTELLARO, M.Lancet (British edition). 1991, Num 8781, pp 1525-1526, issn 0140-6736Article

Laboratory diagnosis of antithrombin and heparin cofactor II deficiencyTOLLEFSEN, D. M.Seminars in thrombosis and hemostasis. 1990, Vol 16, Num 2, pp 162-168, issn 0094-6176, 7 p.Article

Antithrombin reduces monocyte and neutrophil CD11b up regulation in addition to blocking platelet activation during extracorporeal circulationRINDER, Christine S; RINDER, Henry M; SMITH, Michael J et al.Transfusion (Philadelphia, PA). 2006, Vol 46, Num 7, pp 1130-1137, issn 0041-1132, 8 p.Article

Functional determination of antithrombin III in clinical samples and therapeutic concentratesJAWED FAREED; WALENGA, J. M; SVENDSEN, L. G et al.Seminars in thrombosis and hemostasis. 1986, Vol 12, Num 4, pp 328-334, issn 0094-6176Article

Thrombin generation and inactivation in the presence of antithrombin III and heparinLINDHOUT, T; BARUCH, D; SCHOEN, P et al.Biochemistry (Easton). 1986, Vol 25, Num 20, pp 5962-5969, issn 0006-2960Article

Laboratory tests for antithrombin deficiencyKHOR, Bernard; VAN COTT, Elizabeth M.American journal of hematology. 2010, Vol 85, Num 12, pp 947-950, issn 0361-8609, 4 p.Article

Manufacturing process for antithrombin III concentrate: Viral validation studies and effects of column re-use on viral safetyFALBO, A.Developments in biologicals. 2003, Vol 113, pp 81-88, issn 1424-6074, 8 p.Conference Paper

Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparinLANE, D. A; FLYNN, A; IRELAND, H et al.British journal of haematology. 1987, Vol 65, Num 4, pp 451-456, issn 0007-1048Article

Heparin and ionic strength-dependent conversion of antithrombin III from an inhibitor to a substrate of α-thrombinOLSON, S. T.The Journal of biological chemistry (Print). 1985, Vol 260, Num 18, pp 10153-10160, issn 0021-9258Article

Compound heterozygosity involving Antithrombin Cambridge II (p.Ala416Ser) in antithrombin deficiencyAGUILA, Sonia; MARTINEZ-MARTINEZ, Irene; VICENTE, Vicente et al.Thrombosis and haemostasis. 2013, Vol 109, Num 3, pp 556-558, issn 0340-6245, 3 p.Article

Humanplasmafraktion Antithrombin IIIDORNHEIM, G.Pharmazie. 1988, Vol 43, Num 1, issn 0031-7144, 55Article

Heparin is procoagulant in the absence of antithrombinSMITH, Stephanie A; MORRISSEY, James H.Thrombosis and haemostasis. 2008, Vol 100, Num 1, pp 160-162, issn 0340-6245, 3 p.Article

Biodistribution of covalent antithrombin-heparin complexesCHINDEMI, Paul A; KLEMENT, Petr; KONECNY, Filip et al.Thrombosis and haemostasis. 2006, Vol 95, Num 4, pp 629-636, issn 0340-6245, 8 p.Article

Some objective considerations for the neutralization of the anticoagulant actions of recombinant hirudinFAREED, J; WALENGA, J. M; PIFARRE, R et al.Haemostasis. 1991, Vol 21, pp 64-72, issn 0301-0147, SUP1Conference Paper

Assessment of interference by heparin cofactor II in the DuPont aca^® antithrombin-III assayHORTIN, G. L; TOLLEFSEN, D. M; SANTORO, S. A et al.American journal of clinical pathology. 1988, Vol 89, Num 4, pp 515-517, issn 0002-9173Article

Antithrombin Glasgow, 393 Arg to His: a P₁ reactive site variant with increased heparin affinity but no thrombin inhibitory activityOWEN, M. C; BERESFORD, C. H; CARRELL, R. W et al.FEBS letters. 1988, Vol 231, Num 2, pp 317-320, issn 0014-5793Article

Specific association of thrombin-antithrombin complexes with a human hepatoma cell lineFAIR, D. S; PLOW, E. F.Thrombosis research. 1986, Vol 41, Num 1, pp 67-78, issn 0049-3848Article

Substitution of antithrombin III in shock and DIC: a randomized studyBLAUHUT, B; KRAMAR, H; VINAZZER, H et al.Thrombosis research. 1985, Vol 39, Num 1, pp 81-89, issn 0049-3848Article

Déficit en antithrombine III induit par l'héparine et déficit constitutionnel en protéine C: à propos d'un cas = Antithrombin III deficiency induced by heparin, and the constitutional deficiency in protein C: one caseVERGOZ, D; KANNAPEL, M. F; HIEAUX, C et al.Phlébologie. 1985, Vol 38, Num 3, pp 425-427, issn 0031-8280Article